Loading...
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
BACKGROUND: We investigated the effect of cholinesterase inhibitors on all-cause discontinuation, efficacy and safety, and the effects of study design-, intervention-, and patient-related covariates on the risk-benefit of cholinesterase inhibitors for Alzheimer’s disease. METHODS: A systematic revie...
Na minha lista:
| Udgivet i: | Int J Neuropsychopharmacol |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5492783/ https://ncbi.nlm.nih.gov/pubmed/28201726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyx012 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|